Literature DB >> 2570604

Neuroleptanesthesia versus thoracic epidural anesthesia for abdominal aortic surgery.

F Bonnet1, C Touboul, A M Picard, J Vodinh, J P Becquemin.   

Abstract

The hemodynamic consequences of abdominal aortic surgery with infrarenal cross-clamping were studied in 21 patients randomized in two groups. In Group I (11 patients), neuroleptanesthesia was utilized, while Group II (10 patients) received thoracic epidural anesthesia at the T8-9 level. Hemodynamic measurements were performed using Swan-Ganz catheters during the surgical procedures in all patients, with special attention to the periods of clamping and unclamping of the abdominal aorta. The thoracic epidural anesthesia group was characterized by greater hemodynamic stability during surgery, while patients in the neuroleptanesthesia group had significant lability of blood pressure, heart rate, and cardiac index. Nevertheless, in the two groups of patients, it is suggested that cardiac function was unfitted to the tissue oxygen demand after unclamping of the aortic prosthesis because the saturation in oxygen of the mixed venous blood and an increase in arteriovenous difference in oxygen were documented. These results point out that, whatever the anesthesia technique, the critical period in abdominal surgery could be aortic unclamping.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570604     DOI: 10.1016/S0890-5096(07)60026-0

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  2 in total

Review 1.  Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials.

Authors:  A Rodgers; N Walker; S Schug; A McKee; H Kehlet; A van Zundert; D Sage; M Futter; G Saville; T Clark; S MacMahon
Journal:  BMJ       Date:  2000-12-16

Review 2.  Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery.

Authors:  Joanne Guay; Sandra Kopp
Journal:  Cochrane Database Syst Rev       Date:  2016-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.